Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Spiro: Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement.... (0.13 sec) 

Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip …

- annals.org
TE Spiro, GJ Johnson, MJ Christie, RM … - Annals of internal …, 1994 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To determine the most
effective and safe dose of enoxaparin to prevent deep venous thrombosis in high-risk ...
Cited by 80 - Related articles - BL Direct - All 5 versions

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for …

- ejbjs.org [PDF] 
CW Colwell, TE Spiro, AA Trowbridge, BA Morris, HC … - The Journal of Bone and …, 1994 - JBJS
The PDF of the article you requested follows this cover page. This is an enhanced PDF from
The Journal of Bone and Joint Surgery ... 1994;76:3-14. J Bone Joint Surg Am. CW Colwell,
TE Spiro, AA Trowbridge, BA Morris, HC Kwaan, JD Blaha, AJ Comerota and VA Skoutakis
Cited by 150 - Related articles - BL Direct - All 3 versions

Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of …

- ejbjs.org
CW Francis, VD Pellegrini Jr, S Totterman, AD Boyd … - The Journal of Bone and …, 1997 - JBJS
The effectiveness and safety of warfarin were compared with those of a low-molecular-weight
heparin (dalteparin) for the prevention of deep-vein thrombosis after total hip arthroplasty in a
prospective, randomized, multi-institutional trial. Patients who were older than eighteen ...
Cited by 128 - Related articles - BL Direct - All 4 versions

Subcutaneous low-molecular weight heparin or oral anticoagulants for the …


K Hamulyak, AW Lensing, J Van der Meer, … - Thrombosis and …, 1995 - ncbi.nlm.nih.gov
OBJECTIVE: To compare efficacy, safety, and feasibility of adjusted-dose oral anticoagulants
(OAC) versus fixed-dose subcutaneous low molecular weight heparin (LMWH) for the prevention
of deep venous thrombosis (DVT) in patients who have undergone elective hip or knee ...
Cited by 79 - Related articles - BL Direct - All 2 versions

Prevention of deep vein thrombosis after total hip replacement. The effect of low- …


A Planes, N Vochelle, M Fagola, J Feret, M … - Journal of Bone & Joint …, 1991 - JBJS (Br)
Enoxaparin, a low-molecular-weight heparin, has been used together with spinal or general
anaesthesia in a prospective, randomised study of 188 consecutive elective hip
replacements. Bilateral venography was performed on all patients on day 13 after ...
Cited by 53 - Related articles - All 3 versions

Low molecular weight heparin associated with spinal anaesthesia and gradual …

- oxfordjournals.org [PDF] 
CM Samama, F Clergue, J Barre, A … - British Journal of …, 1997 - British Jrnl Anaesthesia
Summary The benefit/risk ratio of administering heparin during spinal anaesthesia in patients
undergoing total hip replacement (THR) has not been studied widely. We conducted a
prospective, randomized, double-blind study to compare low molecular weight heparin ( ...
Cited by 41 - Related articles - BL Direct - All 4 versions

Prevention of postoperative venous thrombosis: a randomized trial comparing …


A Planes, N Vochelle, F Mazas, C Mansat, J … - Thrombosis and …, 1988 - ncbi.nlm.nih.gov
A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once daily) with
standard unfractionated calcium heparin administered at a dose of 5,000 units every 8 hours
in patients undergoing elective hip replacement has been performed. Treatment ...
Cited by 168 - Related articles

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium …


R Hull, G Raskob, G Pineo, D Rosenbloom, … - The New England …, 1993 - nejm.highwire.org
Results Among the 1207 patients with interpretable venograms, 231 of 617 patients (37.4
percent) in the warfarin group and 185 of 590 patients (31.4 percent) in the
low-molecular-weight-heparin group had deep-vein thrombosis (P = 0.03). The reduction ...
Cited by 317 - Related articles - BL Direct - All 6 versions

Prevention of deep vein thrombosis after elective hip surgery: a randomized trial …


MN Levine, J Hirsh, M Gent, AG Turpie, J … - Annals of internal …, 1991 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To determine the relative
efficacy and safety of low molecular weight (LMW) heparin (Enoxaparin) compared with ...
Cited by 218 - Related articles - All 3 versions

Prevention of thromboembolism in 190 hip arthroplasties: Comparison of LMW …


MR Lassen, LC Borris, HM Christiansen, KL … - Acta …, 1991 - informahealthcare.com
We report a controlled, randomized comparison of the antithrombotic efficacy and safety of a
LMW heparin versus a placebo in patients undergoing hip arthroplasty . ... The randomized,
double-blind comparative trial in hip surgery took place from February to December 1988 ...
Cited by 89 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google